Items tagged with Scientific research
Norwegian researchers will develop food-grade bacterial vectors as novel TB vaccines (post)
TBVI's research partner Norwegian University of Life Sciences receives a research grant of 10.2 million Norwegian Crowns (1.25 million euro) for the development of new TB vaccines. The grant is awarded by the Norwegian Programme for Global Health and Vaccination Research (GLOBVAC) for the period 1 September 2014- 31 August 2018. The research activitities will be executed in close collaboration with the TBVI network.
Study identifies protein that helps prevent active tuberculosis in infected patients (post)
A UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from developing the active form of the disease. The protein, interleukin-32, was discovered to be one biomarker of adequate host defense against TB.
Scientists devise a barcode for the bacteria that causes tuberculosis (post)
Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the School.
Research suggests new strategies for fighting TB (post)
Researchers from Brown and MIT have shown new details about how a promising new class of antibiotics attacks the bacterium that causes tuberculosis. The research could provide a blueprint for developing drugs aimed at fighting TB.
Making old lungs look new again (post)
COLUMBUS, Ohio – New research shows that the lungs become more inflammatory with age and that ibuprofen can lower that inflammation.
New weapons against multidrug resistance in tuberculosis (post)
Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.
BMC awarded $21 million NIH grant to investigate tuberculosis, improve treatment (post)
(Boston) - Boston Medical Center (BMC) has been awarded a grant from the National Institutes of Health (NIH) to investigate why Mycobacterium tuberculosis infection (MTB) affects individuals so differently. The grant, worth up to $21 million over seven years, will allow researchers at BMC, Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH), to identify the biological factors, or biomarkers, that indicate whether a person infected with the bacteria that causes tuberculosis (TB) is likely to develop symptoms of the disease in their lifetime or will be cured by treatment. The ultimate goal of this research is to develop new tools for more effective prevention and treatment of TB.
Gates Foundation to require open access to journal articles on research it funds (post)
Vox: The Gates Foundation pushes to make more academic research free and open to the public
Insights into tuberculosis using a tropical fish (post)
Researchers from the University of Auckland and Duke University Medical Centre have collaborated to develop a new understanding and possible way of treating tuberculosis.
Drugs to block angiogenesis could provide new treatment for TB (post)
Durham, NC - The body responds to tuberculosis infection by locking the bacterial offenders into tiny clusters of immune cells called granulomas, which are a hallmark of the disease. This containment strategy succeeds at first, but eventually the bacteria manage to break out of these intercellular jails and spread throughout the body.
Page 5 of 74 · Total posts: 0
←First 4 5 6 Last→